Mexidol® — standard of antioxidant neurocytoprotection
- 00:00
The basis of vascular diseases
- 01:05
Decrease in mortality from cardiovascular diseases and the problem of comorbidity
- 02:12
Mexidol® and its role in reducing the ischemia zone
- 03:19
The presentation of the Nobel Prize in Chemistry N.N. Semenov and the idea of creating the drug Mexidol®
- 04:26
Mexidol® is an original drug with antioxidant properties and anti -enyal activity
- 05:56
Mexidol® - action and wide application
- 07:28
Mexidol® is a proven drug with a huge clinical base
- 08:32
Differences in the Mexidol® brand and analogues
- 09:42
Awards and rating among drugs for neurological practice
Rafael Gegamovich Oganov – Doctor of Medical Sciences, Academician of the Russian Academy of Sciences, Professor, Honorary President of the Russian Society of Cardiology
Voronina Tatyana Aleksandrovna – Doctor of Medical Sciences, Professor, Head of the Laboratory of Psychopharmacology, V.V. Zakusov Research Institute of Pharmacology
Anatoly Ivanovich Fedin – Doctor of Medical Sciences, Professor Emeritus, Head of the University Clinic of Neurology at the N.I. Pirogov Russian National Research Medical University, Honored Doctor of the Russian Federation
Zhivolupov Sergey Anatolyevich – Doctor of Medical Sciences, Professor of the Department of Nervous Diseases of the S.M. Kirov Military Medical Academy
Announcement:
Ischemic processes in the heart muscle underlie such common diseases as acute myocardial infarction and stable and unstable angina. Acute or chronic reduction in blood flow to tissues and organs leads to hypoxia and, consequently, energy deficiency and oxidative stress, which can lead to irreversible changes in cells and their death. Understanding the mechanisms of free radical formation laid the foundation for the concept of combating tissue ischemia and the development of a unique Russian drug. Mexidol® is an achievement of the Institute of Pharmacology of the Russian Academy of Medical Sciences. The drug is a combination of two functionally related compounds – 3-oxypyridine and succinate. The main pharmacological effects of Mexidol® include antioxidant, antihypoxant, and membrane-stabilizing properties. Over many years of clinical use, hasMexidol® earned recognition in the medical community and is rightfully considered the benchmark for antioxidant cardio- and neurocytoprotection.
- 00:00
The basis of vascular diseases
- 01:05
Decrease in mortality from cardiovascular diseases and the problem of comorbidity
- 02:12
Mexidol® and its role in reducing the ischemia zone
- 03:19
The presentation of the Nobel Prize in Chemistry N.N. Semenov and the idea of creating the drug Mexidol®
- 04:26
Mexidol® is an original drug with antioxidant properties and anti -enyal activity
- 05:56
Mexidol® - action and wide application
- 07:28
Mexidol® is a proven drug with a huge clinical base
- 08:32
Differences in the Mexidol® brand and analogues
- 09:42
Awards and rating among drugs for neurological practice
Block of articles on this topic
THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.
Source of photos and images Shutterstock.com